Clinical Diabetic Retinopathy - Marashi, Ameen
43,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
22 °P sammeln
  • Broschiertes Buch

Diabetic retinopathy is the fifth leading cause of blindness and is very common in ophthalmic practice, dealing with it is a daily challenge, and treating patients with diabetic retinopathy properly can save sight and improve their quality of life.This book aims to help comprehending the pathology, imaging techniques, therapeutic modalities, patient approach, clinical features and straight forward treatment plans of diabetic retinopathy, maculopathy and their complications in a modern and practical manner with the help of algorithms and illustrations which provides cutting edge information and…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Diabetic retinopathy is the fifth leading cause of blindness and is very common in ophthalmic practice, dealing with it is a daily challenge, and treating patients with diabetic retinopathy properly can save sight and improve their quality of life.This book aims to help comprehending the pathology, imaging techniques, therapeutic modalities, patient approach, clinical features and straight forward treatment plans of diabetic retinopathy, maculopathy and their complications in a modern and practical manner with the help of algorithms and illustrations which provides cutting edge information and covering various clinical scenarios such as proliferative and nonproliferative diabetic retinopathy, vitreous hemorrhage, tractional retinal detachment, rubeosis iridis, central and non-central diabetic macular edema, vitreomacular abnormalities, macular ischemia, and treatment complications.
Autorenporträt
Dr. Ameen Marashi ist ein syrischer Augenarzt, der sich auf Netzhauterkrankungen spezialisiert hat. Er hat zahlreiche Veröffentlichungen und Forschungsartikel im Bereich der Netzhaut verfasst, ist Eigentümer der Marashi Eye Clinic Group und hat das Retinal Assistant Module erfunden, das auf künstlicher Intelligenz basiert und Augenärzten bei der Behandlung von Netzhauterkrankungen hilft.